Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22624054 | 0.86 | ALDH1A1 (0.35) | ALDH1A1 | |
| SCHEMBL19361069 | 0.86 | ALDH1A1 (0.35) | ALDH1A1 | |
| SCHEMBL11911322 | 0.79 | ALDH1A1 (0.35) | ALDH1A1 | |
| SCHEMBL11032985 | 0.78 | LMNA (0.35) | ALDH1A1 | |
| SCHEMBL14561703 | 0.72 | — | — | |
| SCHEMBL2297967 | 0.72 | — | — | |
| SCHEMBL23667242 | 0.72 | ALDH1A1 (0.30) | ALDH1A1 | |
| SCHEMBL369996 | 0.70 | — | — | |
| SCHEMBL1760668 | 0.70 | — | — | |
| SCHEMBL8568302 | 0.69 | ALDH1A1 (0.40) | ALDH1A1TSHRTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230348438-A1 | PYRAZOLE COMPOUND AND PHARMACEUTICAL USE THEREOF | JAPAN TOBACCO INC. (JP) | 2023-11-02 | — | — | US | disclosed |
| US-11779911-B2 | Production of fatty olefin derivatives via olefin metathesis | PROVIVI, INC. (US) | 2023-10-10 | — | — | US | disclosed |
| EP-3551723-B1 | ADDITIVES FOR LIQUID CRYSTAL MIXTURES | MERCK PATENT GMBH (DE) | 2023-09-20 | — | — | EP | disclosed |
| EP-3377465-B1 | PRODUCTION OF FATTY OLEFIN DERIVATIVES VIA OLEFIN METATHESIS | PROVIVI INC (US) | 2023-08-02 | — | — | EP | disclosed |
| WO-2023001670-A1 | LIQUID ELECTROLYTE COMPOSITION, AND ELECTROCHEMICAL CELL COMPRISING SAID ELECTROLYTE COMPOSITION | BAYERISCHE MOTOREN WERKE AKTIENGESELLSCHAFT (DE) | 2023-01-26 | — | — | WO | disclosed |
| WO-2023001671-A1 | LIQUID ELECTROLYTE COMPOSITION, AND ELECTROCHEMICAL CELL COMPRISING SAID ELECTROLYTE COMPOSITION | BAYERISCHE MOTOREN WERKE AKTIENGESELLSCHAFT (DE) | 2023-01-26 | — | — | WO | disclosed |
| US-11542350-B2 | Binuclear olefin polymerization activators | DOW GLOBAL TECHNOLOGIES LLC (US) | 2023-01-03 | — | — | US | disclosed |
| EP-3794663-B9 | RECHARGEABLE BATTERY CELL | INNOLITH TECH AG (CH) | 2022-04-20 | — | — | EP | disclosed |
| US-20220032280-A1 | PRODUCTION OF FATTY OLEFIN DERIVATIVES VIA OLEFIN METATHESIS | PROVIVI, INC. (US) | 2022-02-03 | — | — | US | disclosed |
| US-11077433-B2 | Production of fatty olefin derivatives via olefin metathesis | PROVIVI, INC. (US) | 2021-08-03 | — | — | US | disclosed |
| EP-1737809-B1 | COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR USE IN TREATING METABOLIC DISORDERS | AMGEN INC (US) | 2013-09-18 | — | — | EP | disclosed |
| US-20130095428-A1 | RADIATION-SENSITIVE RESIN COMPOSITION | JSR CORPORATION (JP) | 2013-04-18 | — | — | US | disclosed |
| US-20130085132-A1 | PYRAZOLE COMPOUND AND PHARMACEUTICAL USE THEREOF | JAPAN TOBACCO INC. (JP) | 2013-04-04 | — | — | US | disclosed |
| US-8232416-B2 | Method of manufacturing perfluorinated polyfunctional vinyl ether compound | FUJIFILM CORPORATION (JP) | 2012-07-31 | — | — | US | disclosed |
| US-8232416-B2 | Method of manufacturing perfluorinated polyfunctional vinyl ether compound | FUJIFILM CORPORATION (JP) | 2012-07-31 | — | — | US | disclosed |
| WO-2012050641-A2 | USE OF TRPA1 ANTAGONISTS TO PREVENT OR TREAT INFECTIONS CAUSED BY BIOLOGICAL-WARFARE AGENTS | HYDRA BIOSCIENCES, INC (US) | 2012-04-19 | — | — | WO | disclosed |
| US-20090216030-A1 | METHOD OF MANUFACTURING PERFLUORINATED POLYFUNCTIONAL VINYL ETHER COMPOUND | FUJIFILM CORPORATION (JP) | 2009-08-27 | — | — | US | disclosed |
| EP-0513397-B1 | BENZOHYDROXIMOYLAZOLE DERIVATIVE, PRODUCTION THEREOF AND INSECTICIDE | KUMIAI CHEMICAL INDUSTRY CO (JP) | 1999-04-14 | — | — | EP | disclosed |
| US-5366988-A | Insecticides or aphidicides | KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) | 1994-11-22 | — | — | US | disclosed |
| EP-0513397-A1 | BENZOHYDROXIMOYLAZOLE DERIVATIVE, PRODUCTION THEREOF AND INSECTICIDE | KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) | 1992-11-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090216030-A1 | METHOD OF MANUFACTURING PERFLUORINATED POLYFUNCTIONAL VINYL ETHER COMPOUND | AFF1, AFF4, AFF2 | ALDH1A1 1923/4885TSHR 2340/4885TDP1 2823/4885 |
| US-20230348438-A1 | PYRAZOLE COMPOUND AND PHARMACEUTICAL USE THEREOF | CYP2C19, CYP3A7, CYP3A5 | ALDH1A1 1200/4885TSHR 2282/4885TDP1 3878/4885 |
| US-11542350-B2 | Binuclear olefin polymerization activators | PUF60, C9, C1S | ALDH1A1 1759/4885TSHR 4834/4885TDP1 2535/4885 |
| US-20130085132-A1 | PYRAZOLE COMPOUND AND PHARMACEUTICAL USE THEREOF | SLC5A1, SLC5A2, SLC34A1 | ALDH1A1 676/4885TSHR 2374/4885TDP1 4324/4885 |
| US-11779911-B2 | Production of fatty olefin derivatives via olefin metathesis | SREBF1, F2, SREBF2 | ALDH1A1 1913/4885TSHR 1977/4885TDP1 4344/4885 |
| US-11077433-B2 | Production of fatty olefin derivatives via olefin metathesis | SREBF1, F2, SREBF2 | ALDH1A1 1913/4885TSHR 1977/4885TDP1 4344/4885 |
| US-20220032280-A1 | PRODUCTION OF FATTY OLEFIN DERIVATIVES VIA OLEFIN METATHESIS | SREBF1, F2, SREBF2 | ALDH1A1 1913/4885TSHR 1977/4885TDP1 4344/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.